by Alan McCann | Apr 7, 2016 | Uncategorized
Wins $30,000 first place prize among >150 amazing startups in CA event held April 7th at Stanford Medical school. Sponsored by BioSciKin, a Chinese biotech venture focused on precision medicine. See full article at http://califesciences.org/bioscikin-1/. Fibralign...
by Alan McCann | Jan 12, 2016 | Uncategorized
Fibralign’s first product, the BioBridge® Collagen Matrix has received 510(k) clearance from the FDA on January 07, 2016 for use in soft tissue support/repair (K151083). Click to view. BioBridge is a sterile thread-like surgical mesh designed for use in surgery...
by Alan McCann | Jul 7, 2014 | Uncategorized
Michael Paukshto, PhD, CTO and co-founder of Fibralign Corporation, was awarded the 2014 Best New Investigator Award at the 11th Biennial NLN International Conference. Fibralign has developed and established an end-to-end manufacturing system for production of its...
by Alan McCann | Jul 1, 2014 | Uncategorized
Fibralign won the prestigious Medtech Innovator award at the 2014 WSGRC Medical Device Conference, placing first out of over 300 startups for this top honor and $125,000...
by Alan McCann | Jun 26, 2014 | Uncategorized
A young company developing a product to address secondary lymphedema, a chronic disease with no cure, stole the show at a venture competition held during a recent medical device conference. Working with Stanford University (Stanford, California), Fibralign (Sunnyvale,...
